Veritone Surges 44% After Achieving Awardable Status for DoD AI Contracts
Veritone Inc. (VERI) jumped 43.88% to top the PRISM Emerging Comms & Media Index after its suite of AI-powered tools was officially assessed as "Awardable" for U.S. Department of Defense use on the Platform One (P1) Solutions Marketplace. This designation grants Veritone expanded access to DoD buyers for its tools, including Track, Redact, Investigate, and aiWARE(TM), aimed at accelerating intelligence gathering and analysis across military and federal operations. Already holding sole-source contracts with the U.S. Air Force, Veritone's new status streamlines procurement and positions the company as a leading AI provider in public sector innovation.
Helius Medical Climbs 23% on Positive PoNS Stroke Trial Results
Helius Medical Technologies Inc. (HSDT) rallied 23.22% to lead the PRISM Emerging Healthcare Index following the announcement of strong data from its Stroke Registrational Program for its portable neuromodulation stimulator device. The double-blind, randomized clinical trial met its primary endpoint, showing statistically significant improvement in gait and balance for chronic stroke patients. Backed by minimal adverse events and strong treatment tolerability, the company plans to submit for FDA approval under its breakthrough device designation in Q3 2025.
Other PRISM Mid-Day Movers:
The post PRISM Mid-Day Movers: Defense-Ready AI and Breakthrough Neurotech Spark Optimism appeared first on PRISM MarketView.
COMTEX_467457375/2927/2025-07-21T12:30:23